Capricor Therapeutics (CAPR) News Today $8.07 +0.33 (+4.26%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$8.02 -0.05 (-0.62%) As of 06:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Capricor Therapeutics Up Today?Toggle Visibility of Why Is Capricor Therapeutics Up Today?Capricor Therapeutics, Inc. (CAPR) has seen selling pressure as multiple law firms launch or promote securities class actions and investor alerts against the company, while it also prepares to report second-quarter results. Investors are weighing potential litigation outcomes alongside the upcoming financial update. Neutral Sentiment: Capricor Therapeutics will present its Q2 2025 financial results and host a conference call on August 13, 2025 at 4:30 p.m. ET. Company Q2 2025 Results Announcement Negative Sentiment: Rosen Law Firm reminds investors who bought CAPR shares between October 9, 2024 and July 10, 2025 to secure counsel before the September 15, 2025 lead plaintiff deadline. ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages CAPR Investors Negative Sentiment: The Gross Law Firm announces the filing of a securities class action on behalf of CAPR shareholders. The Gross Law Firm Class Action Filing Negative Sentiment: Bronstein, Gewirtz & Grossman LLC alerts investors with substantial losses in CAPR shares of their opportunity to lead a class action lawsuit. Bronstein, Gewirtz & Grossman Investor Alert Negative Sentiment: GuruFocus reports that CAPR investors should contact The Gross Law Firm before September 15, 2025 to discuss rights under the ongoing securities suit. GuruFocus: Contact Gross Law Firm Negative Sentiment: The Gross Law Firm issues a PR Newswire notice urging shareholders who purchased CAPR during the class period to contact the firm about lead plaintiff appointment. PR Newswire: Gross Law Firm Investor Notice Negative Sentiment: Kirby McInerney LLP reminds CAPR investors of a class action filing and encourages contact with the firm. TMCnet: Kirby McInerney LLP Reminder Negative Sentiment: GuruFocus covers Kirby McInerney LLP’s reminder to CAPR shareholders about the class action and invitation to contact the firm. GuruFocus: Kirby McInerney LLP Alert Negative Sentiment: Pomerantz LLP issues an investor alert investigating claims on behalf of CAPR investors. Pomerantz LLP Investor Alert Negative Sentiment: A second Pomerantz LLP investor alert reiterates the investigation into potential claims for CAPR shareholders. Pomerantz LLP Duplicate Alert Posted 8h agoAI Generated. May Contain Errors. CAPR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Capricor Therapeutics, Inc. (NASDAQ:CAPR) Receives Consensus Rating of "Buy" from Analysts4 hours ago | marketbeat.comROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPRAugust 7 at 8:35 PM | globenewswire.comThe Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Capricor Therapeutics, Inc. (CAPR) ShareholdersAugust 7 at 4:35 PM | globenewswire.comCAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAugust 7 at 4:00 PM | globenewswire.comInvestors in Capricor Therapeutics, Inc. Should Contact The Gross Law Firm Before September 15, ...August 7 at 9:22 AM | gurufocus.comInvestors in Capricor Therapeutics, Inc. Should Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights - CAPRAugust 7 at 8:45 AM | prnewswire.comXTX Topco Ltd Purchases Shares of 54,870 Capricor Therapeutics, Inc. (NASDAQ:CAPR)August 7 at 3:38 AM | marketbeat.comKirby McInerney LLP Reminds Capricor Therapeutics, Inc. (CAPR) Investors of Class Action Filing and Encourages Investors to Contact the FirmAugust 6 at 8:15 PM | tmcnet.comKirby McInerney LLP Reminds Capricor Therapeutics, Inc. ...August 6 at 6:13 PM | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPRAugust 6 at 10:00 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPRAugust 6 at 10:00 AM | prnewswire.comCapricor Therapeutics to Present Second Quarter 2025 Financial Results and Recent Corporate Update on August 13August 6 at 9:00 AM | globenewswire.comLevi & Korsinsky Reminds Capricor Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 – CAPRAugust 5 at 4:18 PM | globenewswire.comCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmAugust 5 at 10:45 AM | prnewswire.comCapricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPRAugust 5 at 10:45 AM | prnewswire.comLevi & Korsinsky Notifies Shareholders of Capricor Therapeutics, Inc.(CAPR) of a Class Action Lawsuit and an Upcoming DeadlineAugust 5 at 8:45 AM | prnewswire.comInvestors in Capricor Therapeutics, Inc. Should Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights – CAPRAugust 4, 2025 | globenewswire.comThe Gross Law Firm Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPRAugust 4, 2025 | prnewswire.comCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud LawsuitAugust 3, 2025 | gurufocus.comROSEN, A LEADING NATIONAL FIRM, Encourages Capricor Therapeutics, Inc. ...August 3, 2025 | gurufocus.comCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud LawsuitAugust 3, 2025 | prnewswire.comROSEN, A LEADING NATIONAL FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPRAugust 3, 2025 | globenewswire.comSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor TherapeuticsAugust 1, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPRAugust 1, 2025 | globenewswire.comClass Action Filed Against Capricor Therapeutics, Inc. (CAPR) Seeking Recovery for Investors - Contact Levi & KorsinskyAugust 1, 2025 | prnewswire.comROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPRJuly 31, 2025 | globenewswire.comContact Levi & Korsinsky by September 15, 2025 Deadline to Join Class Action Against Capricor Therapeutics, Inc. (CAPR)July 31, 2025 | globenewswire.comCAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJuly 31, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPRJuly 31, 2025 | prnewswire.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Therapeutics, Inc. Lawsuit - CAPRJuly 31, 2025 | prnewswire.comCapricor Therapeutics (CAPR) to Release Quarterly Earnings on WednesdayJuly 31, 2025 | marketbeat.comFDA’s Prasad Exits Following Political Backlash Over SareptaJuly 31, 2025 | msn.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Therapeutics, Inc. Lawsuit – CAPRJuly 30, 2025 | globenewswire.comUS FDA's top vaccine official Vinay Prasad leaves agency after 3 monthsJuly 30, 2025 | msn.comCapricor Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CAPRJuly 30, 2025 | theglobeandmail.comRobbins LLP Reminds CAPR Investors with Large Losses of the Class Action Lawsuit on Behalf of Capricor Therapeutics, Inc. ShareholdersJuly 30, 2025 | prnewswire.comUS FDA's top vaccine official Vinay Prasad leaves agency after short stintJuly 30, 2025 | msn.comSarepta, Replimmune, Capricor rise as FDA’s biologics head departsJuly 30, 2025 | msn.comShareholders that lost money on Capricor Therapeutics should contact Faruqi & Faruqi about pending Class Action - CAPRJuly 29, 2025 | prnewswire.comCapricor Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPRJuly 29, 2025 | prnewswire.comDuchenne Muscular Dystrophy Market to Witness Significant Expansion During the Forecast Period (2025–2034) Amidst Advances in Gene Therapy and Novel Drug Approvals | DelveInsightJuly 28, 2025 | finance.yahoo.comCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud LawsuitJuly 28, 2025 | prnewswire.comClass Action Filed Against Capricor Therapeutics, Inc. (CAPR) - September 15, 2025 Deadline to Join – Contact Levi & KorsinskyJuly 28, 2025 | globenewswire.comROSEN, A TOP-RANKED INVESTOR RIGHTS FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPRJuly 28, 2025 | globenewswire.comCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmJuly 28, 2025 | prnewswire.comClass Action Filed Against Capricor Therapeutics, Inc. (CAPR) Seeking Recovery for Investors - Contact The Gross Law FirmJuly 28, 2025 | prnewswire.comSHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)July 28, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPRJuly 27, 2025 | prnewswire.comInvestors who lost money on Capricor Therapeutics, Inc. (CAPR) should contact Levi & Korsinsky about pending Class Action - CAPRJuly 25, 2025 | globenewswire.comCAPR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Capricor Therapeutics, Inc. Securities Class ActionJuly 25, 2025 | globenewswire.com Get Capricor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CAPR and its competitors with MarketBeat's FREE daily newsletter. Email Address CAPR Media Mentions By Week CAPR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CAPR News Sentiment▼0.090.39▲Average Medical News Sentiment CAPR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CAPR Articles This Week▼258▲CAPR Articles Average Week Get Capricor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CAPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SDGR News Today DYN News Today EVO News Today JANX News Today TVTX News Today ANIP News Today AUPH News Today WVE News Today ETNB News Today VERA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CAPR) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Capricor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CAPR Stock Alerts